![](/img/cover-not-exists.png)
A Phase 1 Randomized, DoubleâBlind, PlaceboâControlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MKâ1654 in Healthy Adults
Aliprantis, Antonios O., Wolford, Dennis, Caro, Luzelena, Maas, Brian M., Ma, Hua, Montgomery, Diana L., Sterling, Laura M., Hunt, Allen, Cox, Kara S., Vora, Kalpit A., Roadcap, Brad A., Railkar, RadhJournal:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.883
Date:
October, 2020
File:
PDF, 945 KB
2020